Cryptogenic cirrhosis in the region where obesity is not prevalent

Table 2 Prevalence of obesity and complication in cryptogenic cirrhotic patients and matched controls

	Cryptogenic(n=24)	Control; all(n=72)	HCV-related(n=48)	HBV-related(n=24)
Body mass index: ≥25kg/m2	54.2%	20.8%b	29.2%a	8.3%b
≥30kg/m2	16.7%	1.4%a	2.1%a	0%a
Visceral fat area: ≥100cm2	40.0%	5.3%b	3.7%b	9.1%a
Complication
Type 2 diabetes mellitus	54.2%	26.4%a	35.4%	13.3%b
Hypertriglyceridemia (≥150mg/dL)	20.8%	4.2%a	2.1%b	13.3%
Hypertension	25.0%	15.3%	18.8%	13.3%

^aP < 0.05, ^bP < 0.01 vs Cryptogenic cirrhosis.